Advertisement

Störungen der Blutgerinnung

  • A. Lorentz

Zusammenfassung

Eine massive oder langanhaltende Blutung ist lebensbedrohlich und muß gestillt werden. Soweit es sich nicht um mechanisch bedingte Blutungen handelt, müssen hierzu die angeborenen bzw. erworbenen Störungen der Blutgerinnung rasch diagnostiziert und konsequent behandelt werden. Dies setzt voraus:
  • Kenntnis des Gerinnungssystems,

  • exakte Diagnose der zugrundeliegenden Koagulopathie,

  • Kenntnis der verschiedenen Präparate, die zur Behandlung eingesetzt warden können.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ansell JE, Kumar R, Deykin D (1977) The spectrum of vitamin K deficiency. JAMA 238:40PubMedCrossRefGoogle Scholar
  2. Bick RL (1978) Disseminated intravascular coagulation and related syndromes. Am J Hematol 5:265PubMedCrossRefGoogle Scholar
  3. Bick RL (1985) Congenital coagulation factor defects and von W. Willebrand’s disease. In: Bick RL Disorders of hemostasis and thrombosis. Principles of clinical practice. Thieme, Stuttgart New York, pp 127–156Google Scholar
  4. Bick RL (1985) Hemostasis defects in general surgery, transplantation and the use of prosthetic devices. In: Bick RL Disorder of hemostasis and thrombosis. Principles of clinical practice. Thieme, Stuttgart New York, pp 223–253Google Scholar
  5. Bloom AL (1981) Factor VIII inhibitors revisited. Br J Haematol 49:319PubMedCrossRefGoogle Scholar
  6. Brettler DB (1985) Thrombotic thrombocytopenie purpura. In: Rippe JM, Irvin RS, Alpert JS, Dalen JE (eds) Intensive care medicine. Little, Brown, BostonGoogle Scholar
  7. Camitta B, Stark R, Thomas ED (1985) A plastic anemia. N Engl J Med 306:645CrossRefGoogle Scholar
  8. Cash JD (1977) Disseminated intravascular coagulation. In: Poller L (ed) Recent advances in blood coagulation. Churchill Livingstone, Edinburgh, p 293 ffGoogle Scholar
  9. Cederbaum AI, Blatt PM, Roberts HR (1975) Intravascular coagulation with use of human prothrombin complex concentrates. Ann Intern Med 84:683Google Scholar
  10. Cohn J (1976) Thrombozytopenia in childhood: An evaluation of 433 patients. Scand J Haematol 16:226PubMedCrossRefGoogle Scholar
  11. Daly PA, Schiffer CA, Wiernik PH (1980) Acute promyelocytic leukemia – clinical management of 15 patients. Am J Hematol 8:347PubMedCrossRefGoogle Scholar
  12. Feinstein DJ (1982) Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood 60:284PubMedGoogle Scholar
  13. Forbes CD (1984) Clinical aspects of the hemophilias and their management. In: Ratnoff OD, Forbes CD (eds) Disorders of hemostasis. Grune & Stratton, New York, p 177 ffGoogle Scholar
  14. Hiller E (1987) Hämostasetherapie im septischen Schock. Anästh Intensivmed 28:171Google Scholar
  15. Hiller E, Saal JG, Ostendorf P, Griffith GW (1977) The procoagulant activity of human granulocytes, lymphocytes and monocytes stimulated by endotoxin. Klin Wochenschr 55:751PubMedCrossRefGoogle Scholar
  16. Janson PA, Jubelirer SJ, Weinstein MJ et al. (1980) Treatment of bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303:1318PubMedCrossRefGoogle Scholar
  17. Jochum M, Duswald KH, Hiller E, Fritz H (1983) Plasma levels of human granulocytic elastase-α1-proteinase inhibitor complex (E-α1 PJ) in patients with septicemia and acute leukemia. In: Goldberg D, Werner M (eds) Selected topics in clinical enzymology. De Gruyter, Berlin, p 85ffGoogle Scholar
  18. Klein CA, Blachman MA (1982) Alloantibodies and platelet destruction. Semin Thromb Hemost 8:105PubMedCrossRefGoogle Scholar
  19. Klose R (1987) Blutungskomplikationen bei Polytraumen. In: Mammen EF (Hrsg) Intensivmedizin aktuell: Sicherheit in Diagnose und Therapie von Gerinnungsstörungen. Medizinische Verlagsgesellschaft, MarburgGoogle Scholar
  20. Kreger BE, Craven DE, McCabe WR (1980) Gram-negative bacteremia. IV. Evaluation of clinical features and treatment in 612 patients. Am J Med 68:344PubMedCrossRefGoogle Scholar
  21. Levine PH (1985) The congenital coagulopathies. In: Rippe JM, Irwin RS, Alpert JS, Dalen JE (eds) Intensive care medicine. Little, Brown, Boston TorontoGoogle Scholar
  22. Mammen EF (1983) Factor VIII abnormalities. Semin Thromb Hemost 9:22CrossRefGoogle Scholar
  23. Mayne EF, Madden M, Crothers JS et al. (1981) Highly purified porcine factor VIII in hemophilia A with inhibitors to factor VIII. Br Med J 282:2011Google Scholar
  24. McGrath JM, Stewart GJ (1969) The effects of endotoxin on vascular endothelium. J Exp Med 129:833PubMedCrossRefGoogle Scholar
  25. McMillan R (1981) Chronic idiopathic thrombocytopenic purpura. N Engl J Med 304:1135PubMedCrossRefGoogle Scholar
  26. Meyer JG (1986) Blutgerinnung und Fibrinolyse. Theorie, Praxis, Diagnostik, Therapie, Prophylaxe. Deutscher Ärzte-Verlag, KölnGoogle Scholar
  27. Mielke CH, Kaneshiro MM, Maher LA, Weiner J, Rapaport SJ (1969) The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 34:204PubMedGoogle Scholar
  28. Müller-Berghaus G (1977) Pathophysiology of generalized intravascular coagulation. Semin Thromb Hemost 4:209Google Scholar
  29. Neame PB, Kelton JG, Walker JR, Stewart JO, Nossel HL, Hirsch J (1980) Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood 56:88PubMedGoogle Scholar
  30. Phillips TE, Mammen EF, Selik NR (1984) Wirksamkeit von AT III bei Verbrauchskoagulopathie im Tierversuch. Med Welt 35:1022Google Scholar
  31. Pineo GF, Regorczi F, Hatton MWC et al. (1973) The activation of coagulation by extracts of mucin: a possible pathway of intravascular coagulation accompaning adenocarcinomas. J Lab Clin Med 82:225Google Scholar
  32. Post M, Telfer MD (1975) Surgery in hemophilic patients. J Bone Joint Surg [Am] 57:1136Google Scholar
  33. Rabiner SF (1972) Uremic bleeding. Semin Hematol 17:242Google Scholar
  34. Rybak ME (1985) Thrombocytopenia. In: Rippe JM, Irwin RS, Alpert JS, Dalen JE (eds) Intensive care medicine. Little, Brown, BostonGoogle Scholar
  35. Salmassi S, Ilangovan S, Kasparisin DO (1982) Treatment of hemophilia A with factor VIII inhibitor by plasma exchange transfusion. Plasma Ther Transfus Technol 2:131Google Scholar
  36. Schiffer CA (1984) Transfusion therapie in the critical care setting. In: Shoemaker WC, Thomson WL, Holbrook PR (eds) Textbook of critical care. Saunders, PhiladelphiaGoogle Scholar
  37. Seeler RA (1972) Hemolysis due to anti-A and anti-B in factor VIII preparations. Arch Intern Med 130:101PubMedCrossRefGoogle Scholar
  38. Shambrom E (1970) Rapid correction of AHF deficiency by antihemophilic factor – method four, with special reference to inhibitors. Bibl Haematol 34:52Google Scholar
  39. Shulman NR, Joran JV (1982) Platelet immunology – post transfusion purpura. In: Colman RW, Hirsh J, Marder VJ et al. (eds) Hemostasis and thrombosis: basic principles and clinical practice. Lippincott, Philadelphia, pp 290–297Google Scholar
  40. Spilker D, Kilian J (1987)Google Scholar
  41. Tilsner V (1987) Blutungskomplikationen in der perioperativen Phase. In: Mammen EF (Hrsg) Intensivmedizin aktuell. Sicherheit in Diagnose und Therapie von Gerinnungsstörungen. Medizinische Verlagsgesellschaft, MarburgGoogle Scholar
  42. Vogel GE, Clarmann M von, Komm C, Wirtzfeld A, Oberdorfer A (1984) Antithrombin III in der Diagnose und Therapie der Verbrauchskoagulopathie. Intensivmed 21:155Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • A. Lorentz

There are no affiliations available

Personalised recommendations